{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:36:04Z","timestamp":1783463764816,"version":"3.55.0"},"reference-count":59,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Background\/Objectives: The ReCODE (Reversal of Cognitive Decline) protocol, a precision medicine program for patients with Alzheimer\u2019s disease (AD), has demonstrated promising results in improving cognitive function. However, its impact on mood, specifically depressive symptoms, has been less explored. Depression is highly prevalent in individuals with mild cognitive impairment and AD, shares common risk factors (e.g., systemic inflammation), and negatively affects quality of life and disease trajectory. This study evaluated whether participation in the ReCODE program is associated with measurable improvement in depressive symptoms, as assessed by the Patient Health Questionnaire-9 (PHQ-9). Methods: This retrospective, observational analysis utilized de-identified data from 170 individuals diagnosed with mild to moderate AD enrolled in the ReCODE program. Participants received initial consultations and program orientation. Follow-up visits occurred 31 days post-enrollment, including further guidance on diet, lifestyle, medications, and supplements, along with mood assessment using the PHQ-9. Pre- and post-intervention PHQ-9 scores were analyzed using the non-parametric Wilcoxon signed-rank test. Results: Participants showed a statistically and clinically significant reduction in PHQ-9 scores. Improvement was observed across all baseline depression categories (mild, moderate, and severe). Critically, the proportion of participants scoring above the clinical threshold for depression decreased substantially following the intervention. Conclusions: These findings suggest that the ReCODE precision-medicine framework offers concurrent benefits for both mood and cognition. Extending prior work, our results indicate that the ReCODE program not only benefits cognitive and biological measures but also significantly alleviates depressive symptoms. While the results highlight ReCODE\u2019s potential as a successful multifaceted therapeutic approach addressing both cognitive decline and mental health in Alzheimer\u2019s disease, given the retrospective, uncontrolled design, the findings should be interpreted as associative and hypothesis-generating rather than causal.<\/jats:p>","DOI":"10.3390\/brainsci16010002","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T11:03:46Z","timestamp":1766142226000},"page":"2","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Short-Term Changes in Depressive Symptoms Among Patients with Alzheimer\u2019s Disease Following a Precision Medicine Intervention"],"prefix":"10.3390","volume":"16","author":[{"given":"Rammohan V.","family":"Rao","sequence":"first","affiliation":[{"name":"Apollo Health, Burlingame, CA 94010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Boyd","sequence":"additional","affiliation":[{"name":"CNS Vital Signs, Morrisville, NC 27560, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sho","family":"Okada","sequence":"additional","affiliation":[{"name":"Apollo Health, Burlingame, CA 94010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Lipa","sequence":"additional","affiliation":[{"name":"Apollo Health, Burlingame, CA 94010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Kelly","sequence":"additional","affiliation":[{"name":"Apollo Health, Burlingame, CA 94010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Coward","sequence":"additional","affiliation":[{"name":"Apollo Health, Burlingame, CA 94010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida L.","family":"Bredesen","sequence":"additional","affiliation":[{"name":"Apollo Health, Burlingame, CA 94010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gregory","sequence":"additional","affiliation":[{"name":"Apollo Health, Burlingame, CA 94010, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1984-5220","authenticated-orcid":false,"given":"Dale E.","family":"Bredesen","sequence":"additional","affiliation":[{"name":"Apollo Health, Burlingame, CA 94010, USA"},{"name":"Pacific Neuroscience Institute, Santa Monica, CA 90404, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-190426","article-title":"Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer\u2019s Disease and Related Dementias and Strategic Implications for Stakeholders","volume":"70","author":"Wiley","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1212\/WNL.0000000000000240","article-title":"Contribution of Alzheimer disease to mortality in the United States","volume":"82","author":"James","year":"2014","journal-title":"Neurology"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association (2024). 2024 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement., 20, 3708\u20133821.","DOI":"10.1002\/alz.13809"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Yiannopoulou, K.G., Anastasiou, A.I., Zachariou, V., and Pelidou, S.H. (2019). Reasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent Research. Biomedicines, 7.","DOI":"10.20944\/preprints201909.0270.v1"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Rao, R.V., Kumar, S., Gregory, J., Coward, C., Okada, S., Lipa, W., Kelly, L., and Bredesen, D.E. (2021). ReCODE: A Personalized, Targeted, Multi-Factorial Therapeutic Program for Reversal of Cognitive Decline. Biomedicines, 9.","DOI":"10.3390\/biomedicines9101348"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3233\/JAD-215707","article-title":"Precision Medicine Approach to Alzheimer\u2019s Disease: Successful Pilot Project","volume":"88","author":"Toups","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.18632\/aging.100896","article-title":"Inhalational Alzheimer\u2019s disease: An unrecognized\u2014and treatable\u2014epidemic","volume":"8","author":"Bredesen","year":"2016","journal-title":"Aging"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13024-021-00452-5","article-title":"Protective genes and pathways in Alzheimer\u2019s disease: Moving towards precision interventions","volume":"16","author":"Seto","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3233\/ADR-200185","article-title":"A Comprehensive, Multi-Modal Strategy to Mitigate Alzheimer\u2019s Disease Risk Factors Improves Aspects of Metabolism and Offsets Cognitive Decline in Individuals with Cognitive Impairment","volume":"4","author":"Schechter","year":"2020","journal-title":"J. Alzheimer\u2019s Dis. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Neuvonen, E., Lehtisalo, J., Ngandu, T., Levalahti, E., Antikainen, R., Hanninen, T., Laatikainen, T., Lindstrom, J., Paajanen, T., and Soininen, H. (2022). Associations of Depressive Symptoms and Cognition in the FINGER Trial: A Secondary Analysis of a Randomised Clinical Trial. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051449"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12603-012-0402-8","article-title":"A review of multidomain interventions to support healthy cognitive ageing","volume":"17","author":"Schneider","year":"2013","journal-title":"J. Nutr. Health Aging"},{"key":"ref_13","first-page":"450","article-title":"Reversal of Cognitive Decline: 100 Patients","volume":"8","author":"Bredesen","year":"2018","journal-title":"J. Alzheimer\u2019s Dis. Park."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.18632\/aging.100981","article-title":"Reversal of cognitive decline in Alzheimer\u2019s disease","volume":"8","author":"Bredesen","year":"2016","journal-title":"Aging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jalz.2012.09.012","article-title":"The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER): Study design and progress","volume":"9","author":"Kivipelto","year":"2013","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12603-014-0515-3","article-title":"Paths to Alzheimer\u2019s disease prevention: From modifiable risk factors to biomarker enrichment strategies","volume":"19","author":"Lista","year":"2015","journal-title":"J. Nutr. Health Aging"},{"key":"ref_17","first-page":"18","article-title":"Case Study: A Precision Medicine Approach to Multifactorial Dementia and Alzheimer\u2019s Disease","volume":"11","author":"Ross","year":"2021","journal-title":"J. Alzheimer\u2019s Dis. Park."},{"key":"ref_18","first-page":"133","article-title":"A Personalized 12-week \u201cBrain Fitness Program\u201d for Improving Cognitive Function and Increasing the Volume of Hippocampus in Elderly with Mild Cognitive Impairment","volume":"3","author":"Fotuhi","year":"2016","journal-title":"J. Prev. Alzheimer\u2019s Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11920-022-01355-y","article-title":"Complementary and Integrative Medicine for Neurocognitive Disorders and Caregiver Health","volume":"24","author":"Nguyen","year":"2022","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3233\/JAD-230467","article-title":"Precision Medicine Approach to Alzheimer\u2019s Disease: Rationale and Implications","volume":"96","author":"Bredesen","year":"2023","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3233\/JAD-230004","article-title":"Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline","volume":"94","author":"Sandison","year":"2023","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12966-024-01580-z","article-title":"Effects of combined dietary intervention and physical-cognitive exercise on cognitive function and cardiometabolic health of postmenopausal women with obesity: A randomized controlled trial","volume":"21","author":"Keawtep","year":"2024","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13195-024-01482-z","article-title":"Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer\u2019s disease: A randomized, controlled clinical trial","volume":"16","author":"Ornish","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13195-024-01468-x","article-title":"Integrating a multimodal lifestyle intervention with medical food in prodromal Alzheimer\u2019s disease: The MIND-ADmini randomized controlled trial","volume":"16","author":"Thunborg","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Rao, R.V., Subramaniam, K.G., Gregory, J., Bredesen, A.L., Coward, C., Okada, S., Kelly, L., and Bredesen, D.E. (2023). Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer\u2019s Disease and MCI: A Review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021659"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0006-3223(03)00543-2","article-title":"Depression in Alzheimer\u2019s disease: Heterogeneity and related issues","volume":"54","author":"Lee","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3233\/JAD-148004","article-title":"Phenomenology of Depression in Alzheimer\u2019s Disease","volume":"47","author":"Novais","year":"2015","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: Validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1001\/jama.2020.6504","article-title":"Accuracy of the PHQ-2 Alone and in Combination with the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis","volume":"323","author":"Levis","year":"2020","journal-title":"JAMA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1017\/S0033291719001314","article-title":"Equivalency of the diagnostic accuracy of the PHQ-8 and PHQ-9: A systematic review and individual participant data meta-analysis","volume":"50","author":"Wu","year":"2020","journal-title":"Psychol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/1567205012666150204124310","article-title":"The prevalence of depression in Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"12","author":"Chi","year":"2015","journal-title":"Curr. Alzheimer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41398-020-0839-1","article-title":"Depression-an underrecognized target for prevention of dementia in Alzheimer\u2019s disease","volume":"10","author":"Dafsari","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e70548","DOI":"10.1002\/alz.70548","article-title":"Sex-specific association of depressive symptom trajectories with cognitive decline and clinical progression in mild cognitive impairment","volume":"21","author":"Wang","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrneurol.2011.60","article-title":"Depression and risk of developing dementia","volume":"7","author":"Byers","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/ajp.146.5.577","article-title":"Overview of depression and psychosis in Alzheimer\u2019s disease","volume":"146","author":"Wragg","year":"1989","journal-title":"Am. J. Psychiatry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/wps.20771","article-title":"The clinical characterization of the adult patient with depression aimed at personalization of management","volume":"19","author":"Maj","year":"2020","journal-title":"World Psychiatry"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e2416305","DOI":"10.1001\/jamanetworkopen.2024.16305","article-title":"Bidirectional Associations of Depressive Symptoms and Cognitive Function Over Time","volume":"7","author":"Yin","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1093\/ije\/dyz085","article-title":"Exploring the bidirectional associations between loneliness and cognitive functioning over 10 years: The English longitudinal study of ageing","volume":"48","author":"Yin","year":"2019","journal-title":"Int. J. Epidemiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1192\/bjp.2018.155","article-title":"Persistent depressive symptoms and cognitive decline in older adults","volume":"213","author":"Zheng","year":"2018","journal-title":"Br. J. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"595","DOI":"10.18632\/aging.100801","article-title":"Metabolic profiling distinguishes three subtypes of Alzheimer\u2019s disease","volume":"7","author":"Bredesen","year":"2015","journal-title":"Aging"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"707","DOI":"10.18632\/aging.100690","article-title":"Reversal of cognitive decline: A novel therapeutic program","volume":"6","author":"Bredesen","year":"2014","journal-title":"Aging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"E191","DOI":"10.1503\/cmaj.110829","article-title":"Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): A meta-analysis","volume":"184","author":"Manea","year":"2012","journal-title":"Can. Med Assoc. J."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Sun, Y., Fu, Z., Bo, Q., Mao, Z., Ma, X., and Wang, C. (2020). The reliability and validity of PHQ-9 in patients with major depressive disorder in psychiatric hospital. BMC Psychiatry, 20.","DOI":"10.1186\/s12888-020-02885-6"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"l1476","DOI":"10.1136\/bmj.l1476","article-title":"Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: Individual participant data meta-analysis","volume":"365","author":"Levis","year":"2019","journal-title":"BMJ"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jamapsychiatry.2020.4364","article-title":"Internet-Based Cognitive Behavioral Therapy for Depression: A Systematic Review and Individual Patient Data Network Meta-analysis","volume":"78","author":"Karyotaki","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/s13063-020-04344-9","article-title":"Patient-reported outcome measures for monitoring primary care patients with depression (PROMDEP): Study protocol for a randomised controlled trial","volume":"21","author":"Kendrick","year":"2020","journal-title":"Trials"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e5951","DOI":"10.1002\/gps.5951","article-title":"A nurse-led positive psychological intervention among elderly community-dwelling adults with mild cognitive impairment and depression: A non-randomized controlled trial","volume":"38","author":"Yao","year":"2023","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1523\/JNEUROSCI.3562-15.2016","article-title":"Direct Transcriptional Effects of Apolipoprotein E","volume":"36","author":"Theendakara","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"5243","DOI":"10.1007\/s12035-017-0757-2","article-title":"Transcriptional Effects of ApoE4: Relevance to Alzheimer\u2019s Disease","volume":"55","author":"Theendakara","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"ref_50","first-page":"e9061","article-title":"Efficacy of a Multimodal Online Lifestyle Intervention for Depressive Symptoms and Quality of Life in Individuals with a History of Major Depressive Disorder","volume":"12","author":"Abbott","year":"2020","journal-title":"Cureus"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Oakes-Cornellissen, A., Morton, D., Rankin, P., and Renfrew, M. (2023). Efficacy of a multimodal lifestyle intervention (The Lift Project) for improving the mental health of individuals with an affective mood disorder living in South Africa. Front. Psychol., 14.","DOI":"10.3389\/fpsyg.2023.1127068"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e27402","DOI":"10.1002\/ppul.27402","article-title":"Predictors of Selective Serotonin Reuptake Inhibitor Treatment Failure in Persons with Cystic Fibrosis","volume":"60","author":"Pettit","year":"2025","journal-title":"Pediatr. Pulmonol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Yi, J., Lu, J., Yang, A., and Marsh, E.B. (2022). In-hospital predictors of post-stroke depression for targeted initiation of Selective Serotonin Reuptake Inhibitors (SSRIs). BMC Psychiatry, 22.","DOI":"10.1186\/s12888-022-04378-0"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2215-0366(19)30366-9","article-title":"The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): A pragmatic, double-blind, placebo-controlled randomised trial","volume":"6","author":"Lewis","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"ref_55","first-page":"453","article-title":"Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants","volume":"82","author":"Zlotogorski","year":"2004","journal-title":"J. Affect. Disord."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jamda.2012.06.003","article-title":"Testing the PHQ-9 interview and observational versions (PHQ-9 OV) for MDS 3.0","volume":"13","author":"Saliba","year":"2012","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/gps.5074","article-title":"Measurement validity of the Patient-Health Questionnaire-9 in US nursing home residents","volume":"34","author":"Belanger","year":"2019","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/gps.2632","article-title":"How do the PHQ-2, the PHQ-9 perform in aging services clients with cognitive impairment?","volume":"26","author":"Boyle","year":"2011","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1017\/S1041610222000175","article-title":"Detecting depression in persons living with mild cognitive impairment: A systematic review","volume":"34","author":"Wong","year":"2022","journal-title":"Int. Psychogeriatr."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/16\/1\/2\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T11:24:09Z","timestamp":1766143449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/16\/1\/2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["brainsci16010002"],"URL":"https:\/\/doi.org\/10.3390\/brainsci16010002","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]}}}